KELER TIBOR 4
4 · Celldex Therapeutics, Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
KELER TIBOR
Sr. VP & CSO
Transactions
- Award
Incentive Stock Option (right to buy)
2023-06-15+92,000→ 92,000 totalExercise: $36.87From: 2024-06-15Exp: 2033-06-15→ Common Stock (92,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]25% vest on June 15, 2024 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.